Comparative Pharmacology
Head-to-head clinical analysis: CHLOROFAIR versus HIBICLENS.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHLOROFAIR versus HIBICLENS.
CHLOROFAIR vs HIBICLENS
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Chloramphenicol inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation.
Chlorhexidine gluconate is a cationic bisbiguanide antiseptic that disrupts microbial cell membranes by binding to negatively charged cell wall components, causing leakage of cytoplasmic contents and precipitation of proteins. It has broad-spectrum activity against Gram-positive and Gram-negative bacteria, fungi, and some viruses.
125 mg IV every 6 hours for 10 days.
Apply 5 mL to wet skin, lather, and rinse thoroughly after 1 minute. For preoperative showering, use 5 mL twice daily for 2 days before surgery. For surgical scrub, brush 5 mL for 2 minutes, then rinse. For hand wash, use 5 mL for 15 seconds.
None Documented
None Documented
4.5 hours (prolonged to 10–12 hours in renal impairment)
Not applicable due to negligible systemic absorption; topical application results in skin retention with minimal systemic exposure.
Renal: 70% unchanged; hepatic metabolism: 25% conjugated; fecal: 5%
Renal: <1% unchanged; fecal: >99% as chlorhexidine; biliary: negligible.
Category C
Category C
Antiseptic
Antiseptic